State Street Corp Gelesis Holdings, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$0.22 - $0.51 $1,458 - $3,380	-6,628 Reduced 3.93%	161,860 $46,000
Q3 2022 Nov 15, 2022	BUY	$0.08 - $1.34 $650 - $10,896	8,132 Added 5.07%	168,488 $182,000
Q2 2022 Aug 15, 2022	BUY	N/A	105,132 Added 190.37%	160,356 $249,000
Q1 2022 May 16, 2022	BUY	N/A	55,224 New	55,224 $250,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.